Diogo Almeida-Rios1,2, #, Inês Graça1,4, #, Filipa Quintela Vieira1,4, João Ramalho-Carvalho1, Eva Pereira-Silva1, Ana Teresa Martins1,2, Jorge Oliveira3, Céline S. Gonçalves5,6, Bruno M. Costa5,6, Rui Henrique1,2,7, *, Carmen Jerónimo1,7, *
1 Cancer Biology & Epigenetics Group Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal